The Kable

The Kable

Friday Kable

๐Ÿ’‰ AstraZeneca puts in $2 billion on radiopharma; Novo goes big in China; Merck bets big on Korea

#509 | Novartis' big aims for Singapore; AbbVie bets on IBD; A future without babies

Vinod's avatar
Vinod
Mar 22, 2024
โˆ™ Paid

Hello, and welcome back to a fully loaded week of updates with The Kable, your weekly fix from the world of life sciences.

The Africa CDC has been making all the right moves and noises on its mission to manufacture 60% of vaccines used on the continent locally by 2040. One of the factors involved in this mission is obviously human capital. In its latest โ€ฆ

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
ยฉ 2026 The Kable ยท Privacy โˆ™ Terms โˆ™ Collection notice
Start your SubstackGet the app
Substack is the home for great culture